2002
DOI: 10.1001/archderm.138.6.751
|View full text |Cite
|
Sign up to set email alerts
|

Celecoxib, a Cyclooxygenase 2 Inhibitor as a Potential Chemopreventive to UV-Induced Skin Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
60
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(60 citation statements)
references
References 39 publications
(36 reference statements)
0
60
0
Order By: Relevance
“…Accumulated data support the idea that an increased expression of COX-2 plays a significant role in different disease processes, including several cancers (3)(4). Anticancer effects are also reported for COX-2 inhibitors in adenocarcinoma of the colon, lung cancer, intestinal polyposis (5-6) and in skin cancers (7)(8).…”
Section: Introductionmentioning
confidence: 65%
“…Accumulated data support the idea that an increased expression of COX-2 plays a significant role in different disease processes, including several cancers (3)(4). Anticancer effects are also reported for COX-2 inhibitors in adenocarcinoma of the colon, lung cancer, intestinal polyposis (5-6) and in skin cancers (7)(8).…”
Section: Introductionmentioning
confidence: 65%
“…12,13 A decrease in the formation of UV-induced skin tumors in mice that received celecoxib (89% reduction) or indomethacin (78% reduction) was observed. 37,38 A reduction in more than 50% of UVR-induced skin tumors in naked mice receiving nimesulide -a selective inhibitor of COX-2 -was also observed. 39 Additionally, celecoxib inhibited the growth of melanoma cells, even in strains not expressing COX-2.…”
Section: Discussionmentioning
confidence: 85%
“…14,50 In addition, in murine models of skin carcinogenesis, it has been shown that administration of NSAIDs, especially selective Cox-2 inhibitors, reduces the prevalence and multiplicity of UV light-induced neoplasms 9,51,52 strongly implying direct involvement of Cox-2 in cutaneous carcinogenesis. Furthermore, specific inhibitors of Cox-2 such as celecoxib have been shown not only to decrease tumorigenesis and increase tumor latency in hairless mice models, 53 but also to decrease tumor growth in hairless mice with pre-existing UVB-induced tumors. 54 However, chronic long-term use of these medications has been associated with a number, in some cases life-threatening, side effects including decreased gastric protection that may lead to gastrointestinal bleeding, impairment of renal function, and inhibition of platelet aggregation 55 and most recently, increased incidence of myocardial infarction in elderly.…”
Section: Discussionmentioning
confidence: 99%